Effect and safety of paroxetine for vasomotor symptoms: systematic review and meta-analysis.

about

Effect and safety of paroxetine for vasomotor symptoms: systematic review and meta-analysis.

Item

http://www.wikidata.org/entity/Q38803432

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Effect and safety of paroxetin ...... atic review and meta-analysis.

@en

type

Item

label

Effect and safety of paroxetin ...... atic review and meta-analysis.

@en

prefLabel

Effect and safety of paroxetin ...... atic review and meta-analysis.

@en

P1476

Effect and safety of paroxetin ...... matic review and meta-analysis

@en

P2093

C Wu

http://www.w3.org/2001/XMLSchema#string

K H Yang

http://www.w3.org/2001/XMLSchema#string

L Yao

http://www.w3.org/2001/XMLSchema#string

Q Wang

http://www.w3.org/2001/XMLSchema#string

Q Wu

http://www.w3.org/2001/XMLSchema#string

X Q Wang

http://www.w3.org/2001/XMLSchema#string

Y Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Suicide attempts in clinical trials with paroxetine randomised against placebo.

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

Critical appraisal of paroxetine for the treatment of vasomotor symptoms

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

Common adverse events associated with an SSRI: meta-analysis of early paroxetine data.

Even more suicide attempts in clinical trials with paroxetine randomised against placebo.

A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer.

The 2012 hormone therapy position statement of: The North American Menopause Society.

FDA approval of paroxetine for menopausal hot flushes.

P304

1735-1743

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1111/1471-0528.13951

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P50

D Wei

P577

2016-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27062457

http://www.w3.org/2001/XMLSchema#string